Soleno Therapeutics (SLNO) Tax Provisions (2026)

Soleno Therapeutics' (SLNO) quarterly Tax Provisions came in at $3.5 million in Q1 2026.

Soleno Therapeutics (SLNO) Tax Provisions (2026) Analysis & Trends

Soleno Therapeutics (SLNO) has 1 years of Tax Provisions data on file, last reported at $3.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 125,146.46
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -859,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 31.86 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -60.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn 3.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.54 Mn